338 related articles for article (PubMed ID: 14758572)
41. Calcitonin measurements for early detection of medullary thyroid carcinoma or its premalignant conditions in Hashimoto's thyroiditis.
Schuetz M; Beheshti M; Oezer S; Novotny C; Paul M; Hofmann A; Bieglmayer C; Niederle B; Kletter K; Dudczak R; Karanikas G; Pirich C
Anticancer Res; 2006; 26(1B):723-7. PubMed ID: 16739344
[TBL] [Abstract][Full Text] [Related]
42. Refining calcium test for the diagnosis of medullary thyroid cancer: cutoffs, procedures, and safety.
Mian C; Perrino M; Colombo C; Cavedon E; Pennelli G; Ferrero S; De Leo S; Sarais C; Cacciatore C; Manfredi GI; Verga U; Iacobone M; De Pasquale L; Pelizzo MR; Vicentini L; Persani L; Fugazzola L
J Clin Endocrinol Metab; 2014 May; 99(5):1656-64. PubMed ID: 24552221
[TBL] [Abstract][Full Text] [Related]
43. Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer.
Kratzsch J; Petzold A; Raue F; Reinhardt W; Bröcker-Preuss M; Görges R; Mann K; Karges W; Morgenthaler N; Luster M; Reiners C; Thiery J; Dralle H; Fuhrer D
Clin Chem; 2011 Mar; 57(3):467-74. PubMed ID: 21159900
[TBL] [Abstract][Full Text] [Related]
44. Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements.
Engelbach M; Görges R; Forst T; Pfützner A; Dawood R; Heerdt S; Kunt T; Bockisch A; Beyer J
J Clin Endocrinol Metab; 2000 May; 85(5):1890-4. PubMed ID: 10843170
[TBL] [Abstract][Full Text] [Related]
45. Hypercalcitoninemia in thyroid conditions other than medullary thyroid carcinoma: a comparative analysis of calcium and pentagastrin stimulation of serum calcitonin.
Lorenz K; Elwerr M; Machens A; Abuazab M; Holzhausen HJ; Dralle H
Langenbecks Arch Surg; 2013 Mar; 398(3):403-9. PubMed ID: 23408061
[TBL] [Abstract][Full Text] [Related]
46. Clinical review: Incidentally discovered medullary thyroid cancer: diagnostic strategies and treatment.
Ahmed SR; Ball DW
J Clin Endocrinol Metab; 2011 May; 96(5):1237-45. PubMed ID: 21346073
[TBL] [Abstract][Full Text] [Related]
47. CGRP radioreceptor assay: a new diagnostic tool for medullary thyroid carcinoma.
Wimalawansa SJ
J Bone Miner Res; 1993 Apr; 8(4):467-73. PubMed ID: 8475796
[TBL] [Abstract][Full Text] [Related]
48. Routine serum calcitonin measurement in the evaluation of thyroid nodules.
Elisei R
Best Pract Res Clin Endocrinol Metab; 2008 Dec; 22(6):941-53. PubMed ID: 19041824
[TBL] [Abstract][Full Text] [Related]
49. Increased calcitonin level in thyroid nodules without medullary carcinoma.
Gibelin H; Essique D; Jones C; Levillain P; Maréchaud R; Kraimps JL
Br J Surg; 2005 May; 92(5):574-8. PubMed ID: 15779075
[TBL] [Abstract][Full Text] [Related]
50. Basal calcitonin levels and the response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis as indicators of medullary carcinoma.
Kotzmann H; Schmidt A; Scheuba C; Kaserer K; Watschinger B; Söregi G; Niederle B; Vierhapper H
Thyroid; 1999 Sep; 9(9):943-7. PubMed ID: 10524574
[TBL] [Abstract][Full Text] [Related]
51. [Evaluation of an immunoassay for calcitonin].
Sylla Niang M; Lombardo F; Schlumberger M; Bidart JM
Dakar Med; 2008; 53(1):76-83. PubMed ID: 19102121
[TBL] [Abstract][Full Text] [Related]
52. [Influence of the calcitonin assay on the definition of biochemical cure in patients with medullary thyroid carcinoma].
Hartung-Knemeyer V; Müller S; Nagarajah J; Lahner H; Broecker-Preuss M; Bockisch A; Görges R
Nuklearmedizin; 2012; 51(4):125-32. PubMed ID: 22526413
[TBL] [Abstract][Full Text] [Related]
53. RT-PCR-based detection of circulating calcitonin-producing cells in patients with advanced medullary thyroid cancer.
Saller B; Feldmann G; Haupt K; Broecker M; Janssen OE; Roggendorf M; Mann K; Lu M
J Clin Endocrinol Metab; 2002 Jan; 87(1):292-6. PubMed ID: 11788662
[TBL] [Abstract][Full Text] [Related]
54. The diagnostic value of calcitonin measurement in wash-out fluid from fine-needle aspiration of thyroid nodules in the diagnosis of medullary thyroid cancer.
Diazzi C; Madeo B; Taliani E; Zirilli L; Romano S; Granata AR; De Santis MC; Simoni M; Cioni K; Carani C; Rochira V
Endocr Pract; 2013; 19(5):769-79. PubMed ID: 23757613
[TBL] [Abstract][Full Text] [Related]
55. [Calcitonin determination for early diagnosis of medullary thyroid cancer].
Karges W
Chirurg; 2010 Jul; 81(7):620, 622-6. PubMed ID: 20549176
[TBL] [Abstract][Full Text] [Related]
56. Thyroid venous catheterization in the early diagnosis of familial medullary thyroid carcinoma.
Wells SA; Baylin SB; Johnsrude IS; Harrington DP; Mendelsohn G; Ontjes DJ; Cooper CW
Ann Surg; 1982 Nov; 196(5):505-11. PubMed ID: 7125737
[TBL] [Abstract][Full Text] [Related]
57. Serum calcitonin levels with calcium loading tests before and after total thyroidectomy in patients with thyroid diseases other than medullary thyroid carcinoma.
Kudo T; Miyauchi A; Ito Y; Yabuta T; Inoue H; Higashiyama T; Tomoda C; Hirokawa M; Amino N
Endocr J; 2011; 58(3):217-21. PubMed ID: 21358115
[TBL] [Abstract][Full Text] [Related]
58. [Can measurement of basal calcitonin replace the pentagastrin test?].
Vestergaard P; Jönsson AL; Christiansen P; Frohnert J
Ugeskr Laeger; 2008 Oct; 170(41):3238-42. PubMed ID: 18940156
[TBL] [Abstract][Full Text] [Related]
59. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
60. Medullary thyroid cancer.
You YN; Lakhani V; Wells SA; Moley JF
Surg Oncol Clin N Am; 2006 Jul; 15(3):639-60. PubMed ID: 16882502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
